News Hub | News Direct

All Industries


Article thumbnail News Release

DealMaker Appoints Jonathan Stidd as New Chief Marketing Officer

Dealmaker

DealMaker, a trailblazer in online capital raising solutions, is thrilled to announce the promotion of Jonathan Stidd to Chief Marketing Officer (CMO). Jonathan, a leader in digital marketing, steps into his new role to steer DealMaker through its next phase of growth and innovation. " Jonathan's track record of raising over $600 million for issuers digitally has defined this industry. " said Rebecca Kacaba, CEO & Co-Founder of DealMaker. " He leads with vision and drive. His expertise, innovation and strong character are exactly what DealMaker needs to lead the charge into a new era of online capital raising. " As CMO, Jonathan aims to position DealMaker as the definitive brand for capital raising in the digital age. His strategies are poised to leverage DealMaker's sophisticated suite of primary issuance and shareholder management solutions, which have already processed over $2B in transactions and over 1M investments. His vision to empower brands and founders with streamlined capital-raising solutions is a driving force for cutting-edge industry techniques. Jonathan is no stranger to the DealMaker family, having led Reach, the in-house digital marketing agency acquired by DealMaker in 2022. His journey to this point is marked by a series of entrepreneurial successes and a deep-seated passion for digital marketing and growth strategy. Jonathan co-founded Ridge Growth Agency in 2017, quickly establishing it as a powerhouse in digital marketing for equity crowdfunding. Under his leadership, Ridge Growth Agency propelled its clients to achieve hundreds of millions of dollars in financing, culminating in its acquisition by DealMaker. " Joining DealMaker has been a highlight in my career. I'm excited to leverage my experience to further innovate our marketing strategies and help more founders realize their dreams, " said Jonathan Stidd. " DealMaker is at the forefront of online capital raising, and I am thrilled to be part of a team that is not only setting but exceeding industry standards. " Under Jonathan's leadership, DealMaker is set to enhance its market presence and continue its trajectory of success, making capital raising accessible and efficient for issuers and organizations worldwide. For more information about DealMaker and its services, visit dealmaker.tech. About DealMaker DealMaker is making online capital raising mainstream with a sophisticated suite of primary issuance and shareholder management solutions, including investor ranking algorithms and data analytics tools. Its mission is to put brands and founders in control, running streamlined, successful capital raises in one centralized platform for investors globally. The company has offices in Toronto, Canada; Austin, Texas; and Tampa, Florida. Visit DealMaker.tech for more information. Contact Details Natasha Jose natasha.jose@dealmaker.tech Company Website https://www.dealmaker.tech/

February 13, 2024 02:35 PM Eastern Standard Time

Article thumbnail News Release

Gaurav Srivastava sued for his actions in a Theranos-like fraud

PlatoData

Los Angeles, California, February 13, 2024 - ( PlatoData via 500NewsWire) -- A complaint for multiple actions for damages pursuant to California law was filed with the Superior Court of the State of California, Los Angeles County, on 7 February 2024, against Defendant Gaurav Srivastava, Chairperson of another Defendant, an LLC company called ‘Veecon Biotech.’ The complaint has been filed by Jolie Slaton, who, through her entity ‘Medical Innovation Partners International’, entered into sales contracts, interacted, and transacted with Gaurav Srivastava, Scott Davalos and Veecon Biotech in both the USA and internationally. The Defendants are being sued for fraud, amongst other causes of action. The Defendants are alleged to have failed to perform, never intended to perform, and/or ultimately made significant misrepresentations to the Plaintiff, which she relied upon in entering contracts with the Defendants. More specifically, Gaurav Srivastava claimed ownership of the intellectual property rights of a world-class medical device that would allow the detection of various diseases, such as cancer, with saliva testing, akin to the infamous ‘Elizabeth Holmes’ Theranos testing device. The Plaintiff had been mandated by the Defendants as the exclusive sales representative for Veecon, selling medical testing device products in the El Salvador, Costa Rica, Guatemala and Mexico regions. Contrary to their fraudulent misrepresentations, the Defendants did not hold the intellectual property rights to the medical device, and failed to hold any license to sell and distribute the technology. Moreover, the Defendants had no partnership or business relationship with the developer of these medical technologies, as they had falsely represented. The five causes of action detailed within the Complaint against the Defendants consist of Breach of Contract, Intentional Misrepresentation, Negligent Misrepresentation, Promise Without Intent to Perform, and Fraud. Jolie Slaton comments: “I provided Gaurav Srivastava and Scott Davalos with life-long and high-profile contacts in the medical sector. I helped them to meet the right decision makers within prospective client organizations with contracts in the pipeline, but I had no idea that it was a fraud from the very start.” “I have suffered significant damages to me personally and to my business as a result of Gaurav Srivastava and Scott Davalos’ actions. I lost millions of dollars worth of income during those years, suffered extreme reputation damage, not to mention the emotional turmoil this matter has caused. I now hope that justice will be served, and that no one else becomes a victim of the Defendants’ unscrupulous actions.” Please contact natasha@risingsunpr.net for further information. Contact Details Rising Sun natasha@risingsunpr.net

February 13, 2024 01:59 PM Eastern Standard Time

Article thumbnail News Release

Above Food files Amendment No. 1 to the Form F-4 Registration Statement in connection with its Proposed Business Combination with Bite Acquisition Corp.

Above Food Corp.

New York, NY and Regina, SK – TheNewswire - February 13, 2024 –– Above Food Corp. (“Above Food” or the “Company”), an innovative food company leveraging its vertically integrated supply chain to deliver differentiated ingredients and consumer products, and Bite Acquisition Corp. (NYSE AMERICAN: BITE) (“Bite”), a special purpose acquisition company, announced today the filing by Above Food Ingredients Inc., a direct wholly owned subsidiary of Above Food (“New Above Food”), of Amendment No. 1 to the Form F-4 registration statement (as amended from time to time, the “Registration Statement”), which contains a preliminary proxy statement of Bite and a prospectus of Above Food in connection with the previously announced business combination of Above Food and Bite (the “Business Combination”). Upon the closing of the proposed Business Combination, New Above Food will become a public company and is expected to be listed on the New York Stock Exchange under the ticker symbol “ABVE”.   While the Registration Statement has not yet become effective, and the information contained therein is subject to change, it provides important information about Above Food’s business, differentiated seed-to-fork platform, intellectual property, and vertically integrated manufacturing capabilities, as well as the proposed Business Combination, and the proposals to be considered by Bite's shareholders.   Lionel Kambeitz, Chief Executive Officer at Above Food, said "the filing of the Amended Registration Statement is an important milestone that demonstrates the significant progress made by BITE and Above Food towards the closing of the Business Combination. This important step advances Above Food's plans to access the U.S. capital markets and to accelerate our unique seed-to-fork platform." The proposed Business Combination implies a pro forma enterprise value of approximately US$319 million. Consideration will be 100% in the form of rollover shares, and the proposed Business Combination is expected to provide approximately US$44 million of gross proceeds to fund future facility development and working capital. Above Food has already received US$9.5 million of investments from several high-profile strategic and financial investors, including Lexington Capital (an alternative investments and development group focused on food & agriculture, water and real estate) and Grupo Vida (one of the largest oat manufacturers in the Americas with production and facilities in Mexico, Canada and Chile). These investors' financial commitment to Above Food is expected to generate commercial and operational synergies for Above in the years to come. Above Food’s Investment Highlights   Above Food is a scaled, innovative food company leveraging its vertically integrated supply chain to deliver differentiated ingredients to ~260 customers globally and consumer products to ~35,000 retail points of distribution.     Well-positioned in a high-growth, US$200 billion plant-based market with multiple macroeconomic demand drivers, including food scarcity and insecurity, global supply chain disruption, ESG and sustainability and deepening sector appeal.     Above Food’s vertically integrated sourcing, traceability systems, and regenerative supply chain enables a “Seed-to-Fork” platform that supports a complementary portfolio of ingredients and consumer products.     Verification of quality and integrity through extensive food safety and food supply certifications, including BRC AA, HACCP, Regenerative Organic Certified (ROC), Gluten Free Certification Organization (GFCO), USDA Organic, Certified Kosher (COR), Vegan, Tested Glyphosate Clean, and Non-GMO Verified.     Ownership and control of proprietary seed genetics, and ongoing trait improvements through agronomy, production protocols and natural genetic selection.     Established global distribution network and customer contracts drive revenue predictability.     Above Food is a high-growth business with projected fiscal year through January 2024 revenue of US$309 million (without giving effect to the Atlantic Natural Foods. Inc. acquisition) representing 44% two year revenue CAGR.     Business Combination expected to provide Above Food with approximately US$44 million of gross proceeds, of which US$9.5 million has already been committed, to fund future facility development and working capital.      Advisors   EarlyBirdCapital is acting as financial advisor and capital markets advisor to Bite. Roth Capital Partners, LLC will act as lead placement agent, and ATB Capital Markets and EarlyBirdCapital will act as placement agents, in connection with a PIPE. Latham & Watkins LLP and Gowling WLG (Canada) LLP are acting as legal counsels to Above Food. Greenberg Traurig LLP and MLT Aikins LLP are acting as legal counsels to Bite.   About Above Food   Above Food Corp. is a differentiated, regenerative ingredient company that celebrates delicious products made with real nutritious, flavorful ingredients and delivered with transparency. Above Food’s vision is to create a healthier world — one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, Above Food delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food’s consumer products and brands are available online at www.abovefood.com and in leading grocers across Canada and the United States.   About Bite Acquisition Corp.   Bite Acquisition Corp is a special purpose acquisition company formed for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Bite is led by Chair and CEO Alberto Ardura and a team of successful industry executives, and venture capital investors who have long track records of operating business in the restaurant and food industries.     Cautionary Statement Regarding Forward-Looking Statements   Certain statements included in this Press Release that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or events that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of financial and performance metrics and projections of market opportunity. These statements are based on various assumptions, whether or not identified in this Press Release, and on the current expectations of Above Food’s and Bite’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Above Food and Bite. These forward-looking statements are subject to a number of risks and uncertainties, including (i) changes in domestic and foreign business, market, financial, political and legal conditions; (ii) the inability of the parties to successfully or timely consummate the proposed Business Combination, including the risk that any required regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect the combined company, the expected benefits of the proposed Business Combination or that the approval of the stockholders of Bite or Above Food is not obtained, any of the other conditions to closing are not satisfied or that events or other circumstances give rise to the termination of the business combination agreement relating to the proposed Business Combination; (iii) changes to the structure of the proposed Business Combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining the necessary regulatory approvals; (iv) the ability to meet stock exchange listing standards following the consummation of the proposed Business Combination; (v) the risk that the proposed Business Combination disrupts current plans and operations of Above Food as a result of the announcement and consummation of the proposed Business Combination; (vi) failure to realize the anticipated benefits of the proposed Business Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (vii) costs related to the proposed Business Combination; (viii) changes in applicable law or regulations; (ix) risks relating to the uncertainty of the projected financial information with respect to Above Food; (x) the outcome of any legal proceedings that may be instituted against Bite or Above Food; (xi) the effects of competition on Above Food’s future business; (xii) the impact of the COVID-19 pandemic on Above Food’s business; (xiii) the ability of Bite or the combined company to issue equity or equity-linked securities or obtain debt financing in connection with the proposed Business Combination or in the future; (xiv) the enforceability of Above Food’s intellectual property rights, including its copyrights, patents, trademarks and trade secrets, and the potential infringement on the intellectual property rights of others; (xv) Above Food’s ability to execute its planned acquisition strategy, including to successfully integrate completed acquisitions and realize anticipated synergies; and (xvi) those factors discussed under the heading “Risk Factors” in Bite's Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on March 31, 2023, the Registration Statement and other documents filed, or to be filed, by Bite and/or New Above Food with the SEC. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that none of Bite or Above Food presently know or that Bite or Above Food currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Bite’s and Above Food’s expectations, plans or forecasts of future events and views as of the date of this Press Release. Bite and Above Food anticipate that subsequent events and developments may cause Bite’s and Above Food’s assessments to change. However, while Bite and Above Food may elect to update these forward-looking statements at some point in the future, Bite and Above Food specifically disclaim any obligation to do so. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. Accordingly, undue reliance should not be placed upon the forward-looking statements. Certain market data information in this Press Release is based on the estimates of Above Food and Bite management. Above Food and Bite obtained the industry, market and competitive position data used throughout this Press Release from internal estimates and research as well as from industry publications and research, surveys and studies conducted by third parties. Above Food and Bite believe their estimates to be accurate as of the date of this Press Release. However, this information may prove to be inaccurate because of the method by which Above Food or Bite obtained some of the data for its estimates or because this information cannot always be verified due to the limits on the availability and reliability of raw data and the voluntary nature of the data gathering process.   Important Information   This press release does not contain all the information that should be considered concerning the proposed Business Combination and is not intended to form the basis of any investment decision or any other decision in respect of the proposed Business Combination. Investors and security holders and other interested parties are urged to read the Registration Statement, including any amendments thereto, and any other documents filed with the SEC when they become available, carefully and in their entirety because they will contain important information about Bite, Above Food and the proposed Business Combination. Investors and security holders may obtain free copies of the Registration Statement and the definitive proxy statement to be incorporated by reference therein and filed in connection with the Business Combination (when available) and other documents filed with the SEC by Bite or New Above Food through the website maintained by the SEC at http://www.sec.gov. These documents (when they are available) can also be obtained free of charge from Bite upon written request to Bite by emailing alberto@biteacquisitioncorp.com. The definitive proxy statement will also be mailed to holders of Bite’s common stock in connection with Bite’s solicitation of proxies for the vote by Bite’s stockholders regarding the proposed Business Combination and related matters.   Participants in the Solicitation   Bite and Above Food and their respective directors and certain of their respective executive officers, other members of management and employees, under SEC rules, may be considered participants in the solicitation of proxies with respect to the proposed Business Combination. Information about the directors and executive officers of Bite is included in Bite’s Annual Report on Form 10-K, filed with the SEC on March 31, 2023, which is available free of charge at the SEC’s website at www.sec.gov. Additional information regarding the participants in the proxy solicitation and a description of their direct interests, by security holdings or otherwise, is set forth in the Registration Statement and other relevant materials to be filed with the SEC regarding the proposed Business Combination by Bite or New Above Food. Stockholders, potential investors and other interested persons should read the Registration Statement carefully before making any voting or investment decisions. These documents, when available, can be obtained free of charge from the sources indicated above.   No Offer or Solicitation   This communication is for informational purposes only and is not intended to and shall not constitute an offer to sell or exchange, or the solicitation of an offer to sell, exchange, buy or subscribe for any securities or a solicitation of any vote of approval, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law.   Contacts   Media: media@abovefood.com   Investors: investors@abovefood.com

February 13, 2024 01:35 PM Eastern Standard Time

Article thumbnail News Release

Mako Gold sampling identifies large-scale manganese zones

MAKO GOLD LIMITED

Mako Gold Ltd (ASX:MKG) managing director Peter Ledwidge sits down with Proactive’s Jonathan Jackson to discuss geological mapping and rock chip sampling results from its Korhogo Project in Côte d’Ivoire. The company has identified several new multi-kilometre manganese-rich zones and confirmed the continuity of manganese mineralisation. Mako intends to further advance the project with metallurgical testing and a geophysical IP survey to assist in future drill targeting. The company is also hard at work at its flagship Napié Gold Project, with ongoing geological mapping and rock chip sampling in new prospective areas. Results are pointing to high-grade gold targets for drilling. Ledwidge will be putting boots on the ground at the project shortly with Mako's chief geologist to better understand the new east-west structures and conduct on-ground due diligence of Goldridge’s Konan Project with the aim of completing the potential transaction. “The low-cost mapping and rock chip sampling program on our Korhogo Project has been very successful," Ledwidge said. "The identification of several new manganese-rich zones adds further potential to the already significant discovery. "We will further advance the project with metallurgical testing and a complementary geophysical IP survey that will greatly assist in future drill targeting." Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 jonathan@proactiveinvestors.com

February 13, 2024 12:45 PM Eastern Standard Time

Video
Article thumbnail News Release

Kite Hill PR Names Creative AI Company, Crant, Winner of This Year’s “Tech for Good” Program

Kite Hill PR

Kite Hill PR, an award-winning, agile tech PR agency, has selected creative AI company, Crant, as the winner of the third iteration of the agency’s "Tech For Good” program. The initiative offers purpose-driven, pro-social technology companies a custom, three-month, PR program at no cost. Crant was selected from a field of impressive submissions and will receive a comprehensive PR package that includes strategy & external communications recommendations, messaging review & competitor analysis, and content creation. “We are thrilled about the opportunity to work with Kite Hill PR and look forward to shining a light on how AI can be wielded to generate a positive impact in society,” said Alvaro Melendez, CEO and co-founder of Crant. “For us, this is not just about increasing our visibility and reaching new audiences in the marketing world - it’s also about promoting ethical branding and inspiring other companies to become more purpose-driven themselves.” Based in Miami, Florida, Crant is a certified minority-owned startup that harnesses the power of AI to enhance brand marketing efficiency and help brands foster positive impact among consumers, stakeholders and employees. Notably, the company’s AI brand-building platform, Ink Lantern, acts as a round-the-clock monitor for brands, helping them to better understand consumer perceptions and gain critical insight into how to boost engagement. Crant has also developed a DEI Index, which leverages AI to track and measure companies’ DEI efforts and materially improve their progress on DEI overall. Off the back of its latest successful program and increased interest in PR support from mission-driven organizations, the agency has expanded “Tech for Good” into a core practice area to double down on supporting companies that are BIPOC/woman/LGBTQIA+ led or owned and have closed a seed or series A round on an ongoing basis. The expansion of the program builds upon Kite Hill’s commitment to provide PR counsel to, support and provide resources to purpose-driven tech and B2B companies within the adtech, enterprise tech, climate tech, fintech, health tech, and media & entertainment industries on an ongoing basis. “We’re incredibly excited to help Crant build upon and amplify their story in the months ahead,” said Tiffany Guarnaccia, CEO and founder of Kite Hill PR. “Since the agency’s founding, Kite Hill PR has helmed communications efforts for B2B tech companies in many emerging and evolving industries. We believe that companies under the umbrella of “Tech for Good” have a unique opportunity to make a positive impact during a period in history when we’d all like to see more good in the world.” About Kite Hill PR Based in New York City with team members in the UK and across North America, Kite Hill PR is a leading B2B communications and tech PR agency specializing in connecting enterprise technology, media and advertising businesses with key stakeholders. The company's winning approach combines thought leadership, strategy and media relations to drive clients' businesses forward. Kite Hill PR has been recognized as one of the "Top Tech Specialist PR Agencies in NYC,” “Most Powerful PR Firms,” and a “Top 50 PR Firm in America” by the Observer, a “Top B2B Agency” by Ragan Communications and PR Daily, a “Best Place to Work” by PR News and one of "America's Best PR Agencies" by Forbes. About Crant Crant is a creative AI company that has quickly become one of the most innovative companies in the field of data-driven brand intelligence. The company is based in Miami, Florida, and is focused on helping brands have a more positive impact on the world with their marketing efforts. Contact Details Alexandra Morrison TechForGood@KiteHillPR.com

February 13, 2024 12:00 PM Eastern Standard Time

Article thumbnail News Release

Kirk Morrison Helps Launch 29th Annual Kickoff to Rebuild Event During Super Bowl Weekend

YourUpdateTV

Rebuilding Together, a leading national nonprofit organization dedicated to repairing the homes of people in need, partnered with Lowe’s, the Official Home Improvement Sponsor of the NFL, for the 29th annual Kickoff to Rebuild event during Super Bowl weekend. As part of the event, former NFL player, Kirk Morrison, teamed up with Rebuilding Together President and CEO, Caroline Blakely, and Lowe’s Home Improvement District Manager, John Sayre, on a satellite media tour to discuss the event and the important work being done nationwide. A video accompanying this announcement is available at: https://youtu.be/trwi5JJf4JY In neighborhoods nationwide, more than 2.6 million homeowners live in deteriorating, physically inadequate homes that threaten their health and safety, including those near Allegiant Stadium, the site of Super Bowl LVIII. Having a safe and healthy home is foundational to so many aspects of our lives, from a sense of community and safety to physical and mental well-being, to economic security and independence. Through its national network of affiliates, Rebuilding Together works proactively and collaboratively with community leaders, long-term residents, funders, and volunteers to foster dialogue and create safe, healthy communities across the country. Kickoff to Rebuild represents Rebuilding Together’s belief that every neighbor should have the opportunity to live in a safe and healthy home and community, and to remain in the places they call home. To date, through Kickoff to Rebuild, Rebuilding Together has made improvements to more than 176 homes, engaged 5,200 volunteers, and invested $6 million to communities in need. Lowe’s has partnered with Rebuilding Together since 2007, and has worked together to revitalize communities and improve the lives of thousands of our neighbors over the years. In 2023, Lowes announced a two-year, $6 million donation to Rebuilding Together to address urgent housing challenges by providing safe homes for veterans, seniors, people with disabilities, families with children, and neighbors impacted by disaster. This year’s event was led by the nonprofit’s local affiliate, Rebuilding Together Southern Nevada, which has helped provide more than 7,800 Las Vegas families with safer community spaces and healthier homes over the past 30 years. As part of this project, volunteers, local contractors and members of the community came together to provide essential repairs including roof and door replacements, extensive bathroom upgrades, exterior painting, landscaping improvements, and new water heaters all at no cost to the homeowners. Additionally, the Boys & Girls Club of Southern Nevada’s John C. Kish Club received a fresh coat of paint to its large gymnasium to provide a safe and enjoyable place for youth to play, learn, build relationships and grow. To learn more, and to find out how to get involved, visit rebuildingtogether.org Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

February 13, 2024 11:53 AM Eastern Standard Time

Video
Article thumbnail News Release

Far East Gold to start scout drilling at Woyla

FAR EAST GOLD LTD

Far East Gold CEO Shane Menere joins Jonathan Jackson in the Proactive Australia studio to discuss a new phase of scout drilling at the company’s Woyla Copper-Gold Project in Indonesia. The company is focused on the Victory vein within the high-priority Aloe Rek prospect. Menere gives us a quick overview of the company and its Indonesian and Australian assets, before bringing the focus back to Woyla, the significance of previous work done there by Barrick Gold, the extended resource delineation campaign at Rek Rinti and how all the work being done in Indonesia ties into the company’s aims. It’s a busy time ahead for FEG, with plenty of news to come in the coming months. “We are extremely excited at the prospect of drills turning at Aloe Rek. This milestone will be yet another remarkable first for us at Woyla," Menere said. "It is incredible to think it is nearly 27 years to the day from when Barrick had hoped to commence drilling at its priority target, Aloe Rek and that Far East Gold will make this happen." Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 jonathan@proactiveinvestors.com

February 13, 2024 11:15 AM Eastern Standard Time

Video
Article thumbnail News Release

Apple Shareholder: Company’s Actions on Human Rights Don’t Match Its Words

NLPC

Ahead of Apple Inc. ’s annual meeting on February 28, National Legal and Policy Center is highlighting a report it has filed with the Securities and Exchange Commission that explains how the iPhone maker’s claims about its respect for human rights fall far short of its real-world engagements and operations. NLPC, a shareholder in Apple, is sponsoring a proposal (No. 8 on Page 97 of the company’s proxy statement ) that asks the company to explain why its actions fail repeatedly to match its statements and policies regarding human rights, especially considering its ongoing pandering to the government of China. The SEC filing builds on the case made in the proposal, with extensive evidence of Apple’s concern for cheap labor and enormous profits, at the expense of the people who buy and make its products under the brutal communist regime. “Over the past ten years, various shareholders have brought at least six different proposals at Apple annual meetings because of its weaknesses when it comes to protecting human rights,” said Paul Chesser, director of NLPC’s Corporate Integrity Project. “Why does the Board of Directors have to keep addressing this issue? Because they only pay lip service to it, while their Chinese government business partners constantly violate standards of respect and decency. The U.S. State Department actually calls it genocide.” NLPC’s proposal and SEC filing note the following examples where Apple fails to follow its own proclamations regarding human rights, rendering them empty: Apple removed the New York Times ’s apps from the App Store in China in 2017, and removed apps including HKmap.live and Quartz from its offerings, during the protests in Hong Kong in 2019; The company severely restricted use of its AirDrop wireless filesharing feature on users’ iPhones during protests against Chairman Xi Jinping’s “zero COVID” policies in late 2022; The Beijing Municipal Bureau of Justice said in January 2024 that it had cracked Apple’s encryption and was able to track senders. According to The Epoch Times, “That allows local police to find ‘several suspects’ who use the iPhone feature to transmit files containing what authorities have referred to as ‘inappropriate remarks,’ according to the agency;” According to Reuters, “Apple has started requiring new apps to show proof of a Chinese government license before their release on its China App Store, joining local rivals that had adopted the policy years earlier to meet tightening state regulations.” Perhaps most telling, the tech giant lobbied against the Uyghur Forced Labor Prevention Act when it was up for consideration in Congress. “Apple wants to avoid this embarrassing issue so badly, that the Board asked the SEC to prevent our proposal from being heard by our fellow shareholders, by claiming that they were already addressing the issue,” Chesser added. “Fortunately – even under a presidential administration cozy with both Big Tech and China – the SEC staff followed the facts instead of political bias, and decided to allow our proposal at the annual meeting. “We look forward to explaining to our fellow shareholders why Apple’s carelessness over human rights presents fiduciary and reputational risks to the company.” ### For more information or to schedule an interview with Paul Chesser, contact Dan Rene at 202-329-8357 or drene@nlpc.org. Please visit http://www.nlpc.org. Founded in 1991, the National Legal and Policy Center promotes ethics in public life through research, investigation, education and legal action. Contact Details National Legal and Policy Center Dan Rene +1 202-329-8357 drene@nlpc.org Company Website http://www.nlpc.org

February 13, 2024 10:00 AM Eastern Standard Time

Article thumbnail News Release

PathAI Announces Exclusive Collaboration with Roche Tissue Diagnostics to Advance AI-enabled Interpretation for Companion Diagnostics

PathAI

PathAI, Inc., a leading AI-powered precision pathology company, today announced an expanded and exclusive relationship with Roche Tissue Diagnostics (RTD) that will bring AI-enabled interpretation to companion diagnostics. Building upon the success of their initial partnership announced in October of 2021, this expanded collaboration will provide an integrated and streamlined solution for biopharma sponsors looking to develop AI-enabled companion diagnostics. Under this agreement, PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop AI-enabled digital pathology algorithms in the companion diagnostics space. RTD will work exclusively with PathAI for a pre-specified term as the sole external algorithm development company for AI-powered companion diagnostics, while retaining the ability to continue to develop its own algorithms for companion diagnostics. PathAI will retain the ability to freely develop algorithms outside of companion diagnostics. RTD and PathAI will create an integrated CDx assay, plus algorithm development process, to provide biopharma sponsors a seamless solution for AI-enabled companion diagnostics. With the increasing investment in immuno-oncology (IO) and now antibody drug conjugates (ADCs), the need for diagnostic tools that are optimized for patient selection will be critical for development, regulatory, and commercial success. "This collaboration with Roche is a testament to our shared commitment to advancing the field of digital pathology and AI-enabled diagnostics for both drug development and clinical care,” said Dr. Andy Beck, CEO and Co-Founder of PathAI. “High medical value diagnostic products with seamless integration into the laboratory workflow will accelerate the transition to digital pathology as the standard to aid clinicians in diagnosis and biomarker characterization." These co-developed, AI-enabled assays will be commercialized globally through Roche’s navify® Digital Pathology platform. PathAI will continue to distribute its AISight ® Image Management System (IMS), and its broad portfolio of algorithmic products. “As the market leader in companion diagnostics, we strive to continuously bring new innovations in personalized healthcare,” said Jill German, Head of Roche Tissue Diagnostics. “This collaboration with PathAI will allow us to accelerate our ability to meet the demand from biopharma companies looking to develop AI-enabled companion diagnostics, and provide them with a powerful end-to-end solution in the pursuit of precision therapeutics.” To learn more about this partnership, contact PathAI ( BD@PathAI.com ) to organize a meeting. About PathAI, Inc.: PathAI is a recognized leader in the biopharma partnering space, uniquely combining AI-powered pathology solutions with end-to-end central pathology and histology services. The company supports biopharma partners in executing clinical trials where pathology-based endpoints, biomarker classification, and/or superior histology quality are critical to successfully gauging therapeutic efficacy, accelerating drug development for complex diseases. PathAI has already supported multiple Phase 2 clinical trials in NASH, IBD, and breast cancer, as well as oncology neoadjuvant trials, and is now expanding into larger scale global Phase 3 studies, as well as additional indications. PathAI provides a fully integrated approach to clinical trials, enabling pharma partners to leverage the power of AI without the heavy lift of implementation. This helps reduce the impact of challenges associated with clinical trials, including unreliable turnaround times, variable histology, stain or scan/digitization quality, and challenging assessment of histological endpoints. The lab offers all major immunohistochemistry staining platforms, with flexible workflows across different scanners, stains, and biopsy types, which improves the quality of clinical trials. Services include access to PathAI’s extensive network of over 500 US Board Certified pathologists to perform high quality reading with rapid turnaround time in a cost-effective manner, plus seamless integration of PathAI's advanced AI-solutions to ensure high-quality, reproducible results with every scan. PathAI is headquartered in Boston, MA, and manages a CAP/CLIA-certified diagnostics clinical laboratory (formerly known as Poplar Healthcare) – one of the country’s largest anatomic pathology labs – in Memphis, TN. For more information, please visit www.pathai.com. Contact Details SVM Public Relations and Marketing Communications Maggie Naples +1 401-490-9700 pathai@svmpr.com Company Website https://www.pathai.com/

February 13, 2024 10:00 AM Eastern Standard Time

1 ... 446447448449450 ... 3787